clindamycin hydrochloride

English Name: Clindamycin HCl; ClidamycinHydrochloride; methyl 7-chloro-6,7,8-trideoxy-6- ({[(2R) -1-methyl-4-propylpyrrolidinium-2-yl]carbonyl}amino) -1-thio-beta-L-erythro-octopyranoside chloride; methyl 7-chloro-6,7,8-trideoxy-6-{[(4R) -1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside hydrochloride (1:1); (2R, 4S) -N-[2-chloro-1-[(2S, 3S, 4R, 5S, 6S) -3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl] -1-methyl-4-propyl-pyrrolidine-2-carboxamide hydrochloride
EINECS 244-398-6
The molecular formula C18H33CLN2O5SHCL; C18H34CL2
The molecular weight of 461.44
CAS NO. 21462-39-5
Antibiotic drugs.For lincomycin derivatives, since 1970 in China's listed.Antimicrobial spectrum and lincomycin, but strong antibacterial activity, clinical mainly for osteomyelitis, anaerobic bacteria to cause infection, respiratory infection, biliary tract infections, endocarditis, otitis media, skin and soft tissue infection and sepsis.The most common adverse reactions in application: allergic reactions, injection of local stimulation and abnormal liver function, is the most serious of pseudomembranous colitis (PMC).